Introduction
The number of protein complexes whose threedimensional structures have been determined is rising rapidly. T h e Protein Data Bank (PDB [ 13) now includes many examples of protein-protein, protein-hapten, protein-DNA and proteincarbohydrate complexes. Continuing improvements in X-ray crystallography have allowed some of these structures to be determined to high resolution, giving a more accurate picture of the details of specific non-covalent interactions. Furthermore, the technique of molecular replacement has made it easier to determine the structures of closely related proteins, such as members of related families or cases where the same protein is complexed with different ligands. For example, there are almost 200 different serine proteinase structures in the PDB complexed with a wide variety of ligands. Thus, we are now at a stage when it is valuable to bring together information from many structures, with the aim of deriving general principles of molecular recognition, to help in the knowledge-based prediction and modelling of unknown complexes.
In this paper we present the results of some of our recent work on protein-small ligand interactions. (Parallel work on protein-protein interactions will not be presented here because of lack of space.) The results cover three related aspects of molecular recognition. Firstly, since we wished to consider the structures of many different protein-ligand complexes, it was necessary to develop a software tool that would quickly and easily allow us to calculate, display and inspect the interactions between a protein and its ligand. The program LIGPLOT addresses this problem.
Secondly, we wished to compare and contrast enzyme active sites, and consider the evolutionary constraints on a system, which is required to perform catalysis. We began this task by considering the Ser-His-Asp catalytic triad found in the serine proteinases and several other enyzme families. We have developed an approach that involves deriving three-dimensional co-ordinate Abbreviations used: PDB, Protein Data Bank; RMS, root mean square.
templates that characterize the catalytic site. These templates have been used to scan the PDB to search for other proteins containing such triads.
Lastly, we have developed a new approach, embodied in a program called X-SITE, that can predict favourable intermolecular interactions and is therefore useful in the modelling of novel molecules into protein binding sites.
LIGPLOT schematic diagrams of protein-ligand interactions
LIGPLOT is a program that we have developed [2] to generate automatically schematic twodimensional representations of protein-ligand interactions. The diagrams provide a quick and easy means of visualizing the most important interactions between the protein and ligand molecules without the need for a detailed inspection on a graphics terminal of the often complex three-dimensional geometry. T h e program is freely available to academic institutions from our F T P site, and via the World Wide Web at: http: //www.biochem.ucl.ac.uk/ -roman/ligplot/ligplot.
html.
An example is given in Figure 1 . This shows a ligand bound in the active site of the serine proteinase chymotrypsin, PDB code Sgch [3] . T h e ligand is a peptide substrate analogue, GlyAla-Trp, and is shown by the thick bonds, while the interacting residues from the protein are represented by thin bonds. T h e interactions shown are hydrogen bonds (dashed lines) and hydrophobic contacts (spoked arcs) and are computed by the program HBPLUS [4] .
In this example, the enzyme's Ser-His-Asp 'catalytic triad' can be seen in the bottom righthand corner of the picture. It comprises residues Ser-195, His-57 and Asp-102, and the function of these residues is described in the next section. Of the other enzyme residues shown, Gly-193, on the right of Figure 1 , is also catalytically important because it is thought to stabilize the transition state intermediate through hydrogen bonding, whereas Gly-216 and Ser-214 at the top of the diagram are responsible for hydrogen bonding to, and binding, the substrate. On the ligand, Trp-252 binds into the enzyme's speci- 
Structural comparisons of Ser-His-Asp catalytic triads
T h e Ser-His-Asp catalytic triad is one of the best-known functional units in enzymes. These three residues, which occur far apart in the amino acid sequence of the enzyme, come together in a specific conformation in the active site to perform the hydrolytic cleavage of the appropriate bond in the substrate.
This triad occurs both in the serine proteinases [5, 6] , where it cleaves C-N bonds, and in the triacylglycerol lipases [7] , where the bond cleaved is C-0. T h e serine proteases are an ubiquitous group of proteolytic enzymes responsible for a range of physiological responses such as the onset of blood clotting [8] , digestion [9] , arthritis, pancreatitis and pulmonary emphysema. The triacylglycerol lipases are responsible for hydrolysing triglycerides; for example, pancreatic lipase hydrolyses water-insoluble triacylglycerols in the intestinal lumen and thereby plays an important role in dietary fat absorption.
The catalytic mechanism of these two enzyme types is very similar. The His-Asp pair can be thought of as a diad whereby an Asp carboxyl oxygen hydrogen bonds to the His N" both orientating the His and increasing the pK, of its N" so that the His can act effectively as an acid/ base catalyst. The nucleophilic Ser 0;' hydrogen bonds to the His N" and attacks the substrate, forming the acylenzyme intermediate, which is subsequently hydrolysed by water to form product.
Our aim was to analyse and compare the SerHis-Asp catalytic triads in these proteins and to derive a three-dimensional consensus template that would allow such triads to be automatically identified in any PDB structure to the exclusion of all non-catalytic Ser-His-Asp associations. We used the January 1995 release of the PDB, which contained over 1500 enzyme structures. From these, we were able to extract 192 serine proteinases, four serine-type carboxypeptidases and nine triacylglycerol lipases. We grouped these 205 proteins according to their structural fold, their sequence similarity and finally their function as given by their enzyme classification, or EC, number [ 101.
T h e structures fell into four main fold groups: group 1 contained the trypsin-like serine proteinases (which have a P-sandwich fold); group 2 contained the subtilisin-like serine proteinases (which have an alternating a/P-fold); group 3 contained the serine-type carboxypeptidases; and group 4 contained the triacylglycerol lipases. T h e first group was further subdivided into three subgroups according to sequence homology.
T o derive the three-dimensional template we first extracted all instances of mutually interacting Ser-His-Asp side chains in our dataset. Each triplet was transformed onto a common reference frame defined by the planar ring of the His. Then, for the Ser-His-Asp associations corresponding to catalytic triads, we calculated the mean positions of the two most important .
functional atoms relative to the histidine, namely the Ser 0 ' which interacts with the His N''2, and whichever of the two Asp carboxyl oxygens is interacting with the His N"'. T o remove bias caused by different numbers of PDB structures in each structural group, a separate mean was calculated for each of the structural groups and then these means were themselves averaged to give a final overall mean three-dimensional consensus template.
We could then compare the root mean square (RMS) distance from our three-dimensional template of any Ser-His-Asp association. Figure  2 shows a histogram of these RMS distances for all the Ser-His-Asp associations (including those corresponding to catalytic triads) in our dataset of 205 enzyme structures. T h e black bars show that the vast majority of the catalytic triads lie' within 2.0A of the consensus template. T h e white bars show the triads that have RMS distances greater than 2.0A. On inspection it was found that, in these cases, the catalytic triads have been significantly deformed by the presence of an inhibitor; the most deformed were the cases where the inhibitors were covalently bound to the enzyme as, for example, in the 7-substituted 3-alkoxy-4-chloroisocoumarin molecule, which is bound to the active site of the elastase structure 8est [ 111.
T h e histogram in Figure 2 demonstrates that the three-dimensional template provides a simple means of differentiating between catalytic and non-catalytic associations of His-Ser-Asp residues. In fact, a lower cut-off than 2.0A can be used as even catalytic triads above 1.4A were found to have inhibitors perturbing the structure of the triad.
Another interesting feature of Figure 2 is the large peak at 5A. This corresponds to the noncatalytic triad of Ser-214-His-57-Asp-102, found in a conserved position in all group 1 triads. Indeed, the catalytic triad residues Ser-195-His-57-Asp-102, plus Ser-214, have been described as a 'catalytic tetrad' [ 121.
Although the three-dimensional template is well conserved across all four fold groups, there Figure 3 shows a representative triad from each group. It is clear that the orientation of the Asp and Ser side chains can vary significantly while still allowing the functional requirements of the catalytic triad to be fulfilled.
T o determine whether the catalytic triad conformation also exists in non-enzyme proteins, we extracted all Ser-His-Asp associations from a representative dataset of 632 non-homologous protein structures. We found only two Ser-€Iis-Asp triplets with a RMS distance of less than 2.OA from our template. These are the Ser-99-His-92-Asp-I23 triplet of cyclophilin A, 2cpl [19] , which has a RMS distance of 1 [ZO] , which has a RMS distance of 1.57A. Upon inspection, both these triplets were found to be surrounded by mainly hydrophobic residues, which would severely obstruct any possible substrate binding.
X-SITE: identifying favourable interactions in binding sites
In this final section, we describe a new method that we have recently developed which should prove useful in rational drug design. The method maps out the regions within a given protein's binding site that are favourable for different atom types, that is regions where a given type of atom (carboxyl oxygen, main chain nitrogen, etc.) can make favourable interactions with the main chain and side chain atoms of the protein. The program is called X-SITE (R. .4. Laskowski, J. M. Thornton, C. Humblet and J. Singh, unpublished work) and its outputs are a set of density maps, one for each atom type, which show where the most favourable regions for a given atom type are. The density maps are much like those produced by the semiempirical calculations of Peter Goodford's GRID program and have the same applications, namely they can form the basis for designing improved, or novel, protein ligands, whether by database searches for appropriate small molecules or by de novo design.
The approach differs from that of the GRID program in that it is entirely empirical. The method makes no assumptions about the nature of the forces that exist between atoms; it relies entirely on observed three-dimensional distributions of atom-atom contacts in a non-homologous dataset of 83 high-resolution protein structures.
The principle is as follows. Each protein side chain and main chain in the dataset is broken up into overlapping three-atom fragments. Each fragment is transformed onto a common reference frame and the relative co-ordinates of all atoms in contact with it are recorded. Contouring methods, similar to those of Murray-Rust and Glusker [24] are used to convert the observed spatial distributions of each different atom type around each different fragment into threedimensional density grids, where the higher densities reflect the preferred interaction geometries. The distributions can be normalized relative to one another to provide a means of assessing the relative clustering of the different atom types around the different fragments.
The data from similar fragments in different amino acids are pooled together, increasing the number of data for these fragment types. In all, we use 163 different types of three-atom fragments around which we extract the distributions for 26 different types of probe atoms, giving 26 x 163 contact distributions in all.
Once derived, the distributions are quick and simple to apply to the constituent three-atom fragments of the residues in a given binding site. T h e densities from the overlapping distributions are averaged, and the resultant density map identifies the most favourable regions within the binding site for each probe atom.
We have tested the method on several known enzyme-inhibitor complexes and have observed good agreement between the favourable regions predicted by X-SITE and those occupied by the atoms of the known inhibitors. We are currently developing this approach with the aim of making the software widely available.
